| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000033805 |
| Receipt No. | R000038540 |
| Official scientific title of the study | The efficacy of probiotics on intestinal flora for surgical baby |
| Date of disclosure of the study information | 2018/08/20 |
| Last modified on | 2018/08/19 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The efficacy of probiotics on intestinal flora for surgical baby | |
| Title of the study (Brief title) | The efficacy of probiotics on intestinal flora for surgical baby | |
| Region |
|
|
| Condition | |||||
| Condition | congenital anomaly | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To investigate how intestinal flora in neonatal surgery cases changes by probiotic treatment and new bacterial flora is established. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase IV |
| Assessment | |
| Primary outcomes | Cytokines in blood (IL6, IL10, IL12, IL18, IFNg), IgG, IgA, IgE are measured. DNA analysis of intestinal microflora in feces with next generation sequencer.
For each item, compare with neonatal surgery case / non-surgical case. Blood and fecal samples should be taken at the following schedule. (Surgery case: at birth, immediately before surgery, immediately after surgery, 1st day after surgery, 3rd day, 7th day Non-surgical case: at birth, 1st day after birth, 3rd day, 7th day) We will examine the correlation between postoperative clinical course and the above results. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | After starting feeding, 1 kg of LKM 512 bifidus per day and taking it until discharge date (14 - 28 days)
|
|
| Interventions/Control_2 | Of the newborn hospital admitted to our hospital (including cases transferred from other hospital births), it is divided into 2 groups of surgical cases, surgery not yet performed, and normal neonates | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Of the newborn hospital admitted to our hospital (including cases transferred from other hospital births), surgical cases, non surgical cases, normal newborns are examined
1) From Committee Approval date to born on March 1, 2019 2) The presence or absence of serious complication malformation (chromosomal abnormality, complex heart disease) is not required 3) Whether actively treated, palliative or restrictive treatment was selected |
|||
| Key exclusion criteria | 1) The patient was considered prenatally diagnosed as requiring surgery but was aborted or in utero fetal death.
2) Patients who underwent surgery after 28 days of age |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | MANABU OKAWADA |
| Organization | Juntendo University School of Medicine
|
| Division name | Pediatric General & Urogenital Surgery |
| Address | Hongo 2-1-1, Bunkyo-ku tokyo |
| TEL | 03-3813-3111 |
| manabu-o@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | MANABU OKAWADA |
| Organization | Juntendo University School of Medicine |
| Division name | Pediatric General & Urogenital Surgery |
| Address | Hongo 2-1-1, Bunkyo-ku tokyo |
| TEL | 03-3813-3111 |
| Homepage URL | |
| manabu-o@juntendo.ac.jp | |
| Sponsor | |
| Institute | Juntendo University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kyodo Milk Industry Co. Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kyodo Milk Industry Co. Ltd |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 順天堂大学病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038540 |